(Q48225183)

9 February 2018

title

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. (English)

1 reference

9 February 2018

Leong L Ng

5

0 references

author name string

Russell J O'Brien

1

1 reference

9 February 2018

Iain B Squire

2

1 reference

9 February 2018

Bettina Demme

3

1 reference

9 February 2018

Joan E Davies

4

1 reference

9 February 2018

publication date

1 August 2003

1 reference

9 February 2018

European Journal of Heart Failure

published in

1 reference

9 February 2018

volume

5

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

499-506

1 reference

9 February 2018

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

The current cost of heart failure to the National Health Service in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Hospitalization of patients with heart failure: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Predictors of prognosis in patients with stable mild to moderate heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Primary care physicians: champions of or an impediment to optimal care of the patient with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Plasma brain natriuretic peptide--an independent predictor of cardiovascular mortality in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

The use of acridinium ester-labelled streptavidin in immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic functi

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900098-9

10.1016/S1388-9842(03)00098-9

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018